Skip to content


    Exciting News for WebMD Members!

    We've been busy behind the scenes building new message boards for you. You'll have new and easier ways to find messages, connect with others, and share your stories.

    And, this will all be available on your smartphone or other mobile device!

    What Do You Need to Do?

    The message board you're used to will be closing in the coming weeks. While many of your boards will be making the move to our new home, your posts will not. Want to keep a discussion going? Save posts you want to continue (this includes your member profile story), so that you can re-post them in the new message boards.

    Keep an eye here and on your email inbox, we'll be back in touch soon to give you all the information you need!

    Yours in health,
    WebMD Message Boards Management

    Continuation of Diagnosing AutoImmune Hepatitis
    Melissa Palmer, MD posted:
    Specific Autoimmune Blood Tests

    Specific autoimmune blood tests include a check for elevated immunoglobulin levels, specifically an elevated gamma-globulin or immunoglobulin G (IgG) level. Gamma globulin or IgG levels greater than two times the upper limit of normal are highly suggestive of a diagnosis of AIH. In addition, the presence of antinuclear antibody (ANA), smooth muscle antibody (SMA), and the liver kidney microsomal antibody (anti-LKM) must be searched for. As mentioned previously, these antibodies are known as autoantibodies.
    Autoantibodies do not cause AIH. However, many autoantibodies are produced by the body in people with AIH. ANA and SMA are the most common, and are therefore, considered "markers" of AIH. It should be noted that both ANA and SMA are not specific for AIH. This means they may also occur in liver diseases other than AIH, as well as in diseases of other organs. Approximately 54 percent of people with AIH have both ANA and SMA present in their blood. Other people have one, but not both, of these autoantibodies. ANA occurs alone as a marker of AIH 13 percent of the time and SMA occurs alone as a marker 33 percent of the time. The presence of both autoantibodies is not necessary for the diagnosis to be made. To make things even more confusing - it is possible for people to lack all autoantibodies and still have AIH. This occurs in about 10 - 20 percent of people with AIH. These people are known as autoantibody-negative AIH (type III AIH). (See page xx). It has been found that one or both of these autoantibodies, although not present initially, may appear later in the course of the disease. This is of importance for people who initially test negative for the presence of autoantibodies and thus, have not been given a definitive diagnosis by their doctors.
    When ANA and SMA are present in liver diseases other than AIH, their values tend to be very low and are thought to be of little significance. These autoantibodies are reported to doctors on blood work by dilution titers (the dilution of blood containing a specific antibody). A titer of 1:160 (one to one hundred sixty) or greater is considered a high titer and is highly suggestive of a diagnosis of AIH. Titers of less than 1:80 (one to eighty) are considered low titers and are not necessarily indicative of a diagnosis of AIH. Low titers are often found in other liver disorders and are usually not clinically significant. Note that autoantibody titers can fluctuate from one blood test to the next, and during therapy for AIH, they may disappear altogether. Moreover, the levels of these autoantibodies do not correlate with the severity or prognosis of disease.

    Was this Helpful?
    10 of 17 found this helpful

    Helpful Tips

    Grapefruit Juice-Simple
    There has been a study at the Boston MA Hospital about pure and simple grapefruit juice. It WORKS!!!!! I have been on 3 txs including ... More
    Was this Helpful?
    13 of 27 found this helpful

    Related Drug Reviews

    • Drug Name User Reviews

    Report Problems With Your Medications to the FDA

    FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.